Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02857270
Title A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | AUS

Facility Status City State Zip Country Details
Georgetown University Medical Center Washington District of Columbia 20007 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756-0001 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232-1305 United States Details
Sarah Cannon Cancer Center Nashville Tennessee 37203 United States Details
Tennessee Oncology PLLC Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
St Vincent's Hospital Sydney New South Wales 2010 Australia Details
Linear Clinical Research Ltd Nedlands Western Australia 6009 Australia Details
Gustave Roussy Villejuif Cedex 94805 France Details
Shizuoka Cancer Center Sunto-Gun Shizuoka 411-8777 Japan Details
National Cancer Center Hospital Chuo-ku Tokyo 104-0045 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field